2024 |
Launch One Acquisition Corp. - Ordinary Shares - Class A
|
Independent Director |
- |
- |
2024 |
CERo Therapeutics Holdings Inc.
|
Director |
- |
- |
2023 |
CERo Therapeutics Holdings Inc.
|
Chief Executive Officer and Chairman of the Board |
- |
- |
2022 |
Atreca Inc - Ordinary Shares - Class A
|
Chairman of the Board |
97.8 K |
-42.8 % |
2022 |
Phoenix Biotech Acquisition Corp - Ordinary Shares - Class A
|
Chairman of the Board |
- |
- |
2022 |
CERo Therapeutics Holdings Inc.
|
Chief Executive Officer and Director |
- |
- |
2021 |
Atreca Inc - Ordinary Shares - Class A
|
Chairman of the Board |
171.0 K |
-28.8 % |
2020 |
Atreca Inc - Ordinary Shares - Class A
|
Chairman of the Board |
240.2 K |
274.5 % |
2019 |
Atreca Inc - Ordinary Shares - Class A
|
Chairman of the Board |
64.1 K |
83.2 % |
2018 |
Atreca Inc - Ordinary Shares - Class A
|
Chairman of the Board |
35 K |
- |
2017 |
Opgen Inc
|
- |
16 K |
-63.3 % |
2017 |
Opgen Inc
|
Independent Director |
- |
- |
2016 |
Veracyte Inc
|
- |
90.5 K |
-26.2 % |
2016 |
Opgen Inc
|
Independent Director |
43.6 K |
65.3 % |
2016 |
Veracyte Inc
|
Chairman of the Board |
- |
- |
2015 |
Veracyte Inc
|
Chairman of the Board |
122.6 K |
-16.1 % |
2015 |
Opgen Inc
|
Independent Director |
26.4 K |
- |
2014 |
Veracyte Inc
|
Chairman of the Board |
146.2 K |
1164.5 % |
2014 |
Opgen Inc
|
Independent Director |
- |
- |
2013 |
Veracyte Inc
|
Chairman of the Board |
11.6 K |
- |
2012 |
Veracyte Inc
|
Chairman of the Board |
- |
- |